|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar
|
|
2
|
Zhang YZ, Zhang LH, Gao Y, Li CH, Jia SQ,
Liu N, Cheng F, Niu DY, Cho WC, Ji JF and Zeng CQ: Discovery and
validation of prognostic markers in gastric cancer by genome-wide
expression profiling. World J Gastroenterol. 17:1710–1717. 2011.
View Article : Google Scholar
|
|
3
|
Tkachenko MA, Zhannat NZ, Erman LV,
Blashenkova EL, Isachenko SV, Isachenko OB, Graham DY and Malaty
HM: Dramatic changes in the prevalence of Helicobacter pylori
infection during childhood: A 10-year follow-up study in Russia. J
Pediatr Gastroenterol Nutr. 45:428–432. 2007. View Article : Google Scholar
|
|
4
|
Wang F, Meng W, Wang B and Qiao L:
Helicobacter pylori-induced gastric inflammation and gastric
cancer. Cancer Lett. 345:196–202. 2014. View Article : Google Scholar
|
|
5
|
Yan C, Yu J, Liu Y, Kang W, Ma Z and Zhou
L: MiR-32 promotes gastric carcinoma tumorigenesis by targeting
Kruppel-like factor 4. Biochem Biophys Res Commun. 467:913–920.
2015. View Article : Google Scholar
|
|
6
|
Kim SJ, Wang YG, Lee HW, Kang HG, La SH,
Choi IJ, Irimura T, Ro JY, Bresalier RS and Chun KH: Up-regulation
of neogenin-1 increases cell proliferation and motility in gastric
cancer. Oncotarget. 5:3386–3398. 2014. View Article : Google Scholar
|
|
7
|
Delaunoit T: Latest developments and
emerging treatment options in the management of stomach cancer.
Cancer Manag Res. 3:257–266. 2011. View Article : Google Scholar
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar
|
|
9
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tahara H, Kay MA, Yasui W and Tahara E:
MicroRNAs in Cancer: The 22nd hiroshima cancer seminar/the 4th
Japanese Association for RNA interference joint international
symposium, 30 August 2012, grand prince hotel hiroshima. Jpn J Clin
Oncol. 43:579–582. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang R, Yang C, Ma X, Wang Y, Luo D, Huang
C, Xu Z, Liu P and Yang L: MiR-let-7a inhibits cell proliferation,
migration and invasion by down-regulating PKM2 in gastric cancer.
Oncotarget. 7:5972–5984. 2016.PubMed/NCBI
|
|
14
|
Li J, Dong G, Wang B, Gao W and Yang Q:
miR-543 promotes gastric cancer cell proliferation by targeting
SIRT1. Biochem Biophys Res Commun. 469:15–21. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang H, Yan X, Ji LY, Ji XT, Wang P, Guo
SW and Li SZ: miR-139 functions as an antioncomir to repress glioma
progression through targeting IGF-1 R, AMY-1 and PGC-1β. Technol
Cancer Res Treat. 16:497–511. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Duz MB, Karatas OF, Guzel E, Turgut NF,
Yilmaz M, Creighton CJ and Ozen M: Identification of miR-139-5p as
a saliva biomarker for tongue squamous cell carcinoma: A pilot
study. Cell Oncol (Dordr). 39:187–193. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang HD, Sun DW, Mao L, Zhang J, Jiang
LH, Li J, Wu Y, Ji H, Chen W, Wang J, et al: MiR-139-5p inhibits
the biological function of breast cancer cells by targeting Notch1
and mediates chemosensitivity to docetaxel. Biochem Biophys Res
Commun. 465:702–713. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu W, Hang M, Yuan CY, Wu FL, Chen SB and
Xue K: MicroRNA-139-5p inhibits cell proliferation and invasion by
targeting insulin-like growth factor 1 receptor in human non-small
cell lung cancer. Int J Clin Exp Pathol. 8:3864–3870.
2015.PubMed/NCBI
|
|
20
|
Liu X, Duan B, Dong Y, He C, Zhou H, Sheng
H, Gao H and Zhang X: MicroRNA-139-3p indicates a poor prognosis of
colon cancer. Int J Clin Exp Pathol. 7:8046–8052. 2014.PubMed/NCBI
|
|
21
|
Wong CC, Wong CM, Tung EK, Au SL, Lee JM,
Poon RT, Man K and Ng IO: The microRNA miR-139 suppresses
metastasis and progression of hepatocellular carcinoma by
down-regulating Rho-kinase 2. Gastroenterology. 140:322–331. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shen K, Liang Q, Xu K, Cui D, Jiang L, Yin
P, Lu Y, Li Q and Liu J.: MiR-139 inhibits invasion and metastasis
of colorectal cancer by targeting the type I insulin-like growth
factor receptor. Biochem Pharmacol. 84:320–330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu R, Yang M, Meng Y, Liao J, Sheng J, Pu
Y, Yin L and Kim SJ: Tumor-suppressive function of miR-139-5p in
esophageal squamous cell carcinoma. PLoS One. 8:e770682013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li RY, Chen LC, Zhang HY, Du WZ, Feng Y,
Wang HB, Wen JQ, Liu X, Li XF, Sun Y, et al: MiR-139 inhibits Mcl-1
expression and potentiates TMZ-induced apoptosis in glioma. CNS
Neurosci Ther. 19:477–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dai S, Wang X, Li X and Cao Y:
MicroRNA-139-5p acts as a tumor suppressor by targeting ELTD1 and
regulating cell cycle in glioblastoma multiforme. Biochem Biophys
Res Commun. 467:204–210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yue S, Wang L, Zhang H, Min Y, Lou Y, Sun
H, Jiang Y, Zhang W, Liang A, Guo Y, et al: miR-139-5p suppresses
cancer cell migration and invasion through targeting ZEB1 and ZEB2
in GBM. Tumour Biol. 36:6741–6749. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qiu G, Lin Y, Zhang H and Wu D: miR-139-5p
inhibits epithelial-mesenchymal transition, migration and invasion
of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Biochem Biophys Res Commun. 463:315–321. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang L, Dong Y, Zhu N, Tsoi H, Zhao Z, Wu
CW, Wang K, Zheng S, Ng SS, Chan FK, et al: microRNA-139-5p exerts
tumor suppressor function by targeting NOTCH1 in colorectal cancer.
Mol Cancer. 13:1242014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Luo HN, Wang ZH, Sheng Y, Zhang Q, Yan J,
Hou J, Zhu K, Cheng Y, Xu YL, Zhang XH, et al: MiR-139 targets
CXCR4 and inhibits the proliferation and metastasis of laryngeal
squamous carcinoma cells. Med Oncol. 31:7892014. View Article : Google Scholar : PubMed/NCBI
|
